Sukhatme Mayukh bought ROIV
June 25, 2026 · Form 4 insider transaction
Sukhatme Mayukh bought 500,000 shares of Roivant Sciences Ltd. at $3.85 per share, a transaction worth $1.93M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
500,000
Price
$3.85
Total value
$1.93M
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateJune 25, 2026
Filing dateJune 29, 2026
Shares owned after19,177,617
OwnershipDirect
10b5-1 planNo
AmendedNo